PED320 Pediatric Pharmacology Exam Prep – Real Practice Questions,
Answers & Detailed Rationales (Updated 2026) | Pediatric Drug
Calculations, Medication Administration for Children, Growth &
Development Considerations, Antibiotics & Vaccines, Respiratory &
Cardiac Medications, Pediatric Dosage Safety, Adverse Drug Reactions, IV
Therapy, Clinical Pediatric Medication Scenarios & NCLEX-Style Questions
Question 1: Which physiological factor MOST significantly contributes to altered
oral drug absorption in neonates compared to older children?
A. Increased gastric acid production
B. Prolonged gastric emptying time
C. Enhanced intestinal motility
D. Mature P-glycoprotein transporter activity
CORRECT ANSWER: B. Prolonged gastric emptying time
Rationale: Neonates exhibit prolonged gastric emptying time due to immature
gastrointestinal motility, which can delay the absorption of orally administered drugs.
Gastric acid production is actually decreased in neonates, not increased. Intestinal
motility is reduced rather than enhanced, and P-glycoprotein transporter activity is
immature, not mature, in this population.
Question 2: A 6-month-old infant weighing 7.5 kg requires amoxicillin for acute
otitis media. The prescribed dose is 45 mg/kg/day divided twice daily. What is the
appropriate single dose?
A. 112.5 mg
B. 168.75 mg
C. 225 mg
D. 337.5 mg
CORRECT ANSWER: B. 168.75 mg
Rationale: Total daily dose = 45 mg/kg/day × 7.5 kg = 337.5 mg/day. Divided twice daily:
337.5 mg ÷ 2 = 168.75 mg per dose. Option A represents one-fourth of the daily dose,
Option C is the total daily dose, and Option D is double the required single dose.
Question 3: Which cytochrome P450 enzyme exhibits the MOST significant
developmental delay in activity, potentially affecting drug metabolism in infants
under 6 months?
A. CYP1A2
B. CYP2D6
C. CYP2C9
D. CYP3A4
CORRECT ANSWER: A. CYP1A2
,Rationale: CYP1A2 activity is markedly reduced at birth and reaches adult levels only
after 6-12 months of age, affecting metabolism of drugs like caffeine and theophylline.
CYP3A4 is present at birth though at reduced activity, while CYP2D6 and CYP2C9
mature more rapidly during infancy.
Question 4: In pediatric patients, why is the volume of distribution for water-
soluble drugs typically larger in infants compared to adults?
A. Higher percentage of total body water
B. Increased plasma protein binding
C. Greater adipose tissue composition
D. Enhanced renal tubular secretion
CORRECT ANSWER: A. Higher percentage of total body water
Rationale: Infants have a higher proportion of total body water (approximately 75-80% of
body weight) compared to adults (50-60%), leading to a larger volume of distribution for
hydrophilic drugs. This often necessitates higher weight-based loading doses to achieve
therapeutic concentrations.
Question 5: Which medication requires therapeutic drug monitoring in pediatric
patients due to its narrow therapeutic index and variable pharmacokinetics?
A. Acetaminophen
B. Amoxicillin
C. Phenytoin
D. Ibuprofen
CORRECT ANSWER: C. Phenytoin
Rationale: Phenytoin has a narrow therapeutic index, nonlinear pharmacokinetics, and
significant interindividual variability in metabolism, necessitating therapeutic drug
monitoring to ensure efficacy while avoiding toxicity. The other listed medications have
wider therapeutic windows and typically do not require routine serum concentration
monitoring.
Question 6: What is the PRIMARY reason for avoiding codeine in children under 12
years of age for pain management?
A. Increased risk of gastrointestinal bleeding
B. Risk of life-threatening respiratory depression due to ultrarapid CYP2D6 metabolism
C. Higher incidence of nephrotoxicity
D. Enhanced potential for hepatotoxicity
CORRECT ANSWER: B. Risk of life-threatening respiratory depression due to
ultrarapid CYP2D6 metabolism
Rationale: Codeine is a prodrug requiring CYP2D6 conversion to morphine for analgesic
effect. Children who are ultrarapid metabolizers can convert codeine to morphine
,rapidly, leading to potentially fatal respiratory depression. This risk prompted FDA black
box warnings against codeine use in children under 12.
Question 7: Which factor MOST contributes to increased risk of drug toxicity from
renally eliminated medications in neonates?
A. Enhanced glomerular filtration rate
B. Immature tubular secretion and reabsorption mechanisms
C. Increased renal blood flow
D. Mature organic anion transporter function
CORRECT ANSWER: B. Immature tubular secretion and reabsorption mechanisms
Rationale: Neonates have significantly reduced glomerular filtration rate and immature
tubular function, leading to prolonged elimination half-lives for renally cleared drugs.
This necessitates dose adjustments and extended dosing intervals to prevent
accumulation and toxicity.
Question 8: When calculating pediatric doses using body surface area (BSA), which
formula is MOST commonly applied in clinical practice?
A. Clark's rule
B. Young's rule
C. Mosteller formula
D. Fried's rule
CORRECT ANSWER: C. Mosteller formula
Rationale: The Mosteller formula (BSA (m²) = √[height (cm) × weight (kg) / 3600]) is
widely used due to its simplicity and accuracy. Clark's rule uses weight relative to adult
weight, Young's rule uses age, and Fried's rule is for infants using age in months—none
directly calculate BSA.
Question 9: Which antibiotic class requires dose adjustment in pediatric patients
with cystic fibrosis due to altered pharmacokinetics?
A. Macrolides
B. Aminoglycosides
C. Penicillins
D. Tetracyclines
CORRECT ANSWER: B. Aminoglycosides
Rationale: Children with cystic fibrosis often exhibit increased volume of distribution
and enhanced renal clearance of aminoglycosides, requiring higher weight-based doses
and careful therapeutic drug monitoring to achieve target concentrations while
minimizing ototoxicity and nephrotoxicity risks.
Question 10: What is the MOST appropriate initial pharmacological intervention for
acute severe asthma exacerbation in a 4-year-old child?
, A. Oral prednisolone
B. Inhaled short-acting beta-agonist via spacer
C. Intravenous magnesium sulfate
D. Subcutaneous epinephrine
CORRECT ANSWER: B. Inhaled short-acting beta-agonist via spacer
Rationale: Inhaled short-acting beta-agonists (e.g., albuterol) via metered-dose inhaler
with spacer are first-line therapy for acute asthma exacerbations in children, providing
rapid bronchodilation with minimal systemic side effects. Systemic corticosteroids are
adjunctive, while IV magnesium or subcutaneous epinephrine are reserved for severe,
refractory cases.
Question 11: Which developmental change in hepatic metabolism explains why
chloramphenicol can cause "gray baby syndrome" in neonates?
A. Increased glucuronidation capacity
B. Deficient UDP-glucuronosyltransferase activity
C. Enhanced cytochrome P450 3A4 function
D. Mature sulfation pathways
CORRECT ANSWER: B. Deficient UDP-glucuronosyltransferase activity
Rationale: Neonates have immature UDP-glucuronosyltransferase enzymes, impairing
chloramphenicol glucuronidation and leading to drug accumulation. This causes
mitochondrial toxicity, cardiovascular collapse, and the characteristic gray
discoloration. This risk has largely eliminated chloramphenicol use in neonates.
Question 12: A 2-year-old child presents with fever and requires antipyretic
therapy. Which statement regarding acetaminophen dosing is CORRECT?
A. Maximum single dose should not exceed 15 mg/kg
B. Dosing interval should be every 8 hours regardless of formulation
C. Rectal administration achieves identical bioavailability to oral route
D. Hepatotoxicity risk is negligible at recommended doses
CORRECT ANSWER: A. Maximum single dose should not exceed 15 mg/kg
Rationale: The recommended single dose of acetaminophen in children is 10-15 mg/kg,
with a maximum of 75 mg/kg/day divided every 4-6 hours. Rectal bioavailability is
variable and often lower than oral. While hepatotoxicity is rare at therapeutic doses, it
remains a risk with overdose or in malnourished children.
Question 13: Which medication is CONTRAINDICATED in children under 18 years
with viral infections due to risk of Reye's syndrome?
A. Ibuprofen
B. Naproxen
C. Aspirin
D. Acetaminophen
Answers & Detailed Rationales (Updated 2026) | Pediatric Drug
Calculations, Medication Administration for Children, Growth &
Development Considerations, Antibiotics & Vaccines, Respiratory &
Cardiac Medications, Pediatric Dosage Safety, Adverse Drug Reactions, IV
Therapy, Clinical Pediatric Medication Scenarios & NCLEX-Style Questions
Question 1: Which physiological factor MOST significantly contributes to altered
oral drug absorption in neonates compared to older children?
A. Increased gastric acid production
B. Prolonged gastric emptying time
C. Enhanced intestinal motility
D. Mature P-glycoprotein transporter activity
CORRECT ANSWER: B. Prolonged gastric emptying time
Rationale: Neonates exhibit prolonged gastric emptying time due to immature
gastrointestinal motility, which can delay the absorption of orally administered drugs.
Gastric acid production is actually decreased in neonates, not increased. Intestinal
motility is reduced rather than enhanced, and P-glycoprotein transporter activity is
immature, not mature, in this population.
Question 2: A 6-month-old infant weighing 7.5 kg requires amoxicillin for acute
otitis media. The prescribed dose is 45 mg/kg/day divided twice daily. What is the
appropriate single dose?
A. 112.5 mg
B. 168.75 mg
C. 225 mg
D. 337.5 mg
CORRECT ANSWER: B. 168.75 mg
Rationale: Total daily dose = 45 mg/kg/day × 7.5 kg = 337.5 mg/day. Divided twice daily:
337.5 mg ÷ 2 = 168.75 mg per dose. Option A represents one-fourth of the daily dose,
Option C is the total daily dose, and Option D is double the required single dose.
Question 3: Which cytochrome P450 enzyme exhibits the MOST significant
developmental delay in activity, potentially affecting drug metabolism in infants
under 6 months?
A. CYP1A2
B. CYP2D6
C. CYP2C9
D. CYP3A4
CORRECT ANSWER: A. CYP1A2
,Rationale: CYP1A2 activity is markedly reduced at birth and reaches adult levels only
after 6-12 months of age, affecting metabolism of drugs like caffeine and theophylline.
CYP3A4 is present at birth though at reduced activity, while CYP2D6 and CYP2C9
mature more rapidly during infancy.
Question 4: In pediatric patients, why is the volume of distribution for water-
soluble drugs typically larger in infants compared to adults?
A. Higher percentage of total body water
B. Increased plasma protein binding
C. Greater adipose tissue composition
D. Enhanced renal tubular secretion
CORRECT ANSWER: A. Higher percentage of total body water
Rationale: Infants have a higher proportion of total body water (approximately 75-80% of
body weight) compared to adults (50-60%), leading to a larger volume of distribution for
hydrophilic drugs. This often necessitates higher weight-based loading doses to achieve
therapeutic concentrations.
Question 5: Which medication requires therapeutic drug monitoring in pediatric
patients due to its narrow therapeutic index and variable pharmacokinetics?
A. Acetaminophen
B. Amoxicillin
C. Phenytoin
D. Ibuprofen
CORRECT ANSWER: C. Phenytoin
Rationale: Phenytoin has a narrow therapeutic index, nonlinear pharmacokinetics, and
significant interindividual variability in metabolism, necessitating therapeutic drug
monitoring to ensure efficacy while avoiding toxicity. The other listed medications have
wider therapeutic windows and typically do not require routine serum concentration
monitoring.
Question 6: What is the PRIMARY reason for avoiding codeine in children under 12
years of age for pain management?
A. Increased risk of gastrointestinal bleeding
B. Risk of life-threatening respiratory depression due to ultrarapid CYP2D6 metabolism
C. Higher incidence of nephrotoxicity
D. Enhanced potential for hepatotoxicity
CORRECT ANSWER: B. Risk of life-threatening respiratory depression due to
ultrarapid CYP2D6 metabolism
Rationale: Codeine is a prodrug requiring CYP2D6 conversion to morphine for analgesic
effect. Children who are ultrarapid metabolizers can convert codeine to morphine
,rapidly, leading to potentially fatal respiratory depression. This risk prompted FDA black
box warnings against codeine use in children under 12.
Question 7: Which factor MOST contributes to increased risk of drug toxicity from
renally eliminated medications in neonates?
A. Enhanced glomerular filtration rate
B. Immature tubular secretion and reabsorption mechanisms
C. Increased renal blood flow
D. Mature organic anion transporter function
CORRECT ANSWER: B. Immature tubular secretion and reabsorption mechanisms
Rationale: Neonates have significantly reduced glomerular filtration rate and immature
tubular function, leading to prolonged elimination half-lives for renally cleared drugs.
This necessitates dose adjustments and extended dosing intervals to prevent
accumulation and toxicity.
Question 8: When calculating pediatric doses using body surface area (BSA), which
formula is MOST commonly applied in clinical practice?
A. Clark's rule
B. Young's rule
C. Mosteller formula
D. Fried's rule
CORRECT ANSWER: C. Mosteller formula
Rationale: The Mosteller formula (BSA (m²) = √[height (cm) × weight (kg) / 3600]) is
widely used due to its simplicity and accuracy. Clark's rule uses weight relative to adult
weight, Young's rule uses age, and Fried's rule is for infants using age in months—none
directly calculate BSA.
Question 9: Which antibiotic class requires dose adjustment in pediatric patients
with cystic fibrosis due to altered pharmacokinetics?
A. Macrolides
B. Aminoglycosides
C. Penicillins
D. Tetracyclines
CORRECT ANSWER: B. Aminoglycosides
Rationale: Children with cystic fibrosis often exhibit increased volume of distribution
and enhanced renal clearance of aminoglycosides, requiring higher weight-based doses
and careful therapeutic drug monitoring to achieve target concentrations while
minimizing ototoxicity and nephrotoxicity risks.
Question 10: What is the MOST appropriate initial pharmacological intervention for
acute severe asthma exacerbation in a 4-year-old child?
, A. Oral prednisolone
B. Inhaled short-acting beta-agonist via spacer
C. Intravenous magnesium sulfate
D. Subcutaneous epinephrine
CORRECT ANSWER: B. Inhaled short-acting beta-agonist via spacer
Rationale: Inhaled short-acting beta-agonists (e.g., albuterol) via metered-dose inhaler
with spacer are first-line therapy for acute asthma exacerbations in children, providing
rapid bronchodilation with minimal systemic side effects. Systemic corticosteroids are
adjunctive, while IV magnesium or subcutaneous epinephrine are reserved for severe,
refractory cases.
Question 11: Which developmental change in hepatic metabolism explains why
chloramphenicol can cause "gray baby syndrome" in neonates?
A. Increased glucuronidation capacity
B. Deficient UDP-glucuronosyltransferase activity
C. Enhanced cytochrome P450 3A4 function
D. Mature sulfation pathways
CORRECT ANSWER: B. Deficient UDP-glucuronosyltransferase activity
Rationale: Neonates have immature UDP-glucuronosyltransferase enzymes, impairing
chloramphenicol glucuronidation and leading to drug accumulation. This causes
mitochondrial toxicity, cardiovascular collapse, and the characteristic gray
discoloration. This risk has largely eliminated chloramphenicol use in neonates.
Question 12: A 2-year-old child presents with fever and requires antipyretic
therapy. Which statement regarding acetaminophen dosing is CORRECT?
A. Maximum single dose should not exceed 15 mg/kg
B. Dosing interval should be every 8 hours regardless of formulation
C. Rectal administration achieves identical bioavailability to oral route
D. Hepatotoxicity risk is negligible at recommended doses
CORRECT ANSWER: A. Maximum single dose should not exceed 15 mg/kg
Rationale: The recommended single dose of acetaminophen in children is 10-15 mg/kg,
with a maximum of 75 mg/kg/day divided every 4-6 hours. Rectal bioavailability is
variable and often lower than oral. While hepatotoxicity is rare at therapeutic doses, it
remains a risk with overdose or in malnourished children.
Question 13: Which medication is CONTRAINDICATED in children under 18 years
with viral infections due to risk of Reye's syndrome?
A. Ibuprofen
B. Naproxen
C. Aspirin
D. Acetaminophen
